Brief: Wilex says unit Heidelberg Pharma contracts Suisse CDMO Celonic

Heidelberg Pharma AG

27/09/2016 06:24

Sept 27 (Reuters) - Wilex AG  WL6G.DE : 
    * Subsidiary Heidelberg Pharma contracts Suisse CDMO Celonic 
for antibody cell line development and antibody production 
    * Antibody for ATAC lead candidate HDP-101 to be produced 
under GMP conditions for later clinical development in multiple 
myeloma 
 
Source text for Eikon:  ID:nEQ1K3PC8  
Further company coverage:  WL6G.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))